Back to search

Vacv Biotherapeutics (Uk) Limited

12269783

active
ltd
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

120 Aldersgate Street, London, EC1A 4JQ
Incorporated 18/10/2019

Previously known as

Vacv Biotherapeutics Limited · until 11/05/2022

Compliance

Last accounts

31/12/2025

total exemption full

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 17/10/2025

Due 31/10/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Professor Nicholas Robert Lemoine

director · Since 18/10/2019

DIRECTOR

BRITISH · ENGLAND · Age 68

Also on 2 other boards

Professor Yaohe Wang

director · Since 18/10/2019

DIRECTOR

BRITISH · UNITED KINGDOM · Age 61

Mr Glyn Owain Edwards

director · Since 22/04/2022

EXECUTIVE CHAIRMAN

BRITISH · UNITED KINGDOM · Age 71

Also on 8 other boards

Nicholas Robert Lemoine

director · Since 18/10/2019

British · England · Age 68

Yaohe Wang

director · Since 18/10/2019

British · United Kingdom · Age 61

Glyn Owain Edwards

director · Since 22/04/2022

British · United Kingdom · Age 71

Persons with Significant Control

Former PSCs

Professor Yaohe Wang

Ceased 18/05/2022

Change History

officer appointedEDWARDS, Glyn Owain
2026-07-28
officer appointedLEMOINE, Nicholas Robert, Professor
2026-07-28
officer appointedWANG, Yaohe, Professor
2026-07-28
statusactive
2026-07-28

Active

typeltd
2026-07-28

Private Limited Company

address line1120 Aldersgate Street
2026-07-28

120 ALDERSGATE STREET

post townLondon
2026-07-28

LONDON

CompanyRankvs 1967+ SIC 72110 peers
44

Financial strength24th percentile among SIC peers · 6/25
Employees91th percentile among SIC peers · 14/15
LiquidityCurrent ratio 0.25× · 2/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength6/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2025

Net Worth

£1

Balance sheet strength

Cash

£42k

Cash in the bank

Net Current Assets

-£2.9M

Working capital

Current Assets

£958k

Current Liabilities

£3.9M

Fixed Assets

£769

Debtors

£915k

8avg. employees

Balance Sheet

Assets less current liabilities-£2.9M
Prepared with CCH Software

EstimatesDerived

YearCurrent Ratio
20250.25
20240.10
20230.32

Derived from filed accounts. Not audited figures.